Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference

5/30/25 6:00:00 AM ET

Medical/Dental Instruments

Health Care

Get the next $HAE alert in real time by email

BOSTON, May 30, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 8:40 a.m. ET.

The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://event.webcasts.com/starthere.jsp?ei=1721260&tp_key=3096fdc651&tp_special=8

A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.

ABOUT HAEMONETICS

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:

Olga Guyette, Vice President-Investor Relations & Treasury

(781) 356-9763

[email protected]

David Trenk, Manager-Investor Relations

(203) 733-4987

[email protected]

Media Contact:

Josh Gitelson, Sr. Director-Global Communications

(781) 356-9776

[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-goldman-sachs-46th-annual-global-healthcare-conference-302468741.html

SOURCE Haemonetics Corporation

Get the next $HAE alert in real time by email

Recent Analyst Ratings for

$HAE

Date	Price Target	Rating	Analyst
2/7/2025	$95.00 → $68.00	Neutral → Underperform	BofA Securities
12/6/2024	$116.00	Overweight	Analyst
11/8/2024	$120.00	Outperform → Strong Buy	Raymond James
9/13/2024	$116.00	Buy	CL King
9/11/2024	$85.00	Neutral	BofA Securities
9/10/2024	$112.00	Buy	BTIG Research
6/12/2024	$112.00	Hold → Buy	Needham
10/13/2022	$90.00	Buy	Mizuho

More analyst ratings

Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Chat with this insight

Recent Analyst Ratings for
$HAE

$HAE
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Amendment: EVP and General Counsel Basil Michelle L was granted 6,755 shares, increasing direct ownership by 24% to 35,233 units (SEC Form 4)

Amendment: EVP, Chief Commercial Officer Galvin Roy was granted 5,689 shares, increasing direct ownership by 79% to 12,932 units (SEC Form 4)

SVP, Human Resources Miller Laurie A. was granted 3,195 shares, increasing direct ownership by 12% to 29,163 units (SEC Form 4)

Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Chat with this insight

Recent Analyst Ratings for $HAE

$HAE Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Amendment: EVP and General Counsel Basil Michelle L was granted 6,755 shares, increasing direct ownership by 24% to 35,233 units (SEC Form 4)

Amendment: EVP, Chief Commercial Officer Galvin Roy was granted 5,689 shares, increasing direct ownership by 79% to 12,932 units (SEC Form 4)

SVP, Human Resources Miller Laurie A. was granted 3,195 shares, increasing direct ownership by 12% to 29,163 units (SEC Form 4)

Recent Analyst Ratings for
$HAE

$HAE
Insider Trading